Riboflavin Market, By Form, By Source, By Application, By Geography

Description

Riboflavin market is estimated to be valued at USD 461.5 Mn in 2024 and is expected to reach USD 726.0 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 461.5 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	6.70%	2031 Value Projection:	US$ 726.0 Mn

Figure. Riboflavin Market Share (%), By Region 2024

Riboflavin, also known as vitamin B2, is an essential nutrient required by the human body for growth and development. It plays a vital role in various metabolic processes through its involvement as a precursor for flavin mononucleotide and flavin adenine dinucleotide. As a water-soluble vitamin, riboflavin needs to be supplemented through diet. It is naturally present in a variety of foods including milk, eggs, meat, leafy green vegetables, mushrooms, and legumes. Deficiency of riboflavin can lead to health issues like cracks at the corners of the mouth, inflammation of the mouth, sore throat, itchy skin, and seborrheic dermatitis. Due to growing health awareness and increasing demand for nutritional supplements, global riboflavin can witness growth in the near future.

Market Dynamics-

Global riboflavin market growth is driven by factors such as increasing consumer preference for nutritional supplements, growing health consciousness, rising cases of riboflavin deficiencies, and expanding food & beverage industry. However, high costs associated with natural extraction of riboflavin from foods and synthetic production can hamper the market growth. Novel applications of riboflavin as an additive in pharmaceuticals, cosmetics and animal feed can present new avenues for market expansion. However, the market faces certain restraints due to presence of riboflavin in many routine foods. Strict regulatory norms governing dietary supplements can hamper the market growth. Increasing adoption of vegan and vegetarian diets as riboflavin intake can be challenging through a non-meat diet can offer growth opportunities. Product innovation leading to enhanced formulations presents another favorable growth prospect.

Key Features of the Study-

This report provides in-depth analysis of the global riboflavin market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global riboflavin market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include BASF SE, Koninklijke DSM NV, Shanghai Acebright Pharmaceuticals Group Co. Ltd., Xinfa Pharmaceutical Co. Ltd, Hubei Guangji Pharmaceutical Co. Ltd, NB Group Co. Ltd, Hegno, Legend Industries, Hebei Shengxue dacheng Pharmaceutical Co. Ltd, Duchefa Biochemie, and Harman Finichem Ltd

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global riboflavin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global riboflavin market

Market Segmentation

Form Insights (Revenue, USD, 2019 - 2031)
- Powder
- Liquid
Source Insights (Revenue, USD, 2019 - 2031)
- Plant
- Animal
Application Insights (Revenue, USD, 2019 - 2031)
- Food and Beverages
- Dietary Supplements
- Pharmaceutical
- Animal Feed
- Personal Care
- Others
Regional Insights (Revenue, USD, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- BASF SE
- Koninklijke DSM NV
- Shanghai Acebright Pharmaceuticals Group Co. Ltd.
- Xinfa Pharmaceutical Co. Ltd
- Hubei Guangji Pharmaceutical Co. Ltd
- NB Group Co. Ltd
- Hegno
- Legend Industries
- Hebei Shengxue dacheng Pharmaceutical Co. Ltd
- Duchefa Biochemie
- Harman Finichem Ltd

Product Code: CMI5140

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Form
- Market Snippet, By Source
- Market Snippet, By Application
- Market Snippet, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend

4. Global Riboflavin Market - Impact of Coronavirus (COVID-19) Pandemic

Overview
Factors Affecting the Global Riboflavin Market - COVID-19
Impact Analysis

5. Global Riboflavin Market, By Form, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Powder
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Liquid
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
- Segment Trends

6. Global Riboflavin Market, By Source, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Plant
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Animal
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends

7. Global Riboflavin Market, By Application, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Food and Beverages
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Dietary Supplements
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Pharmaceutical
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Animal Feed
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Personal Care
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Others
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends

8. Global Riboflavin Market, By Region, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020 - 2031
North America
- Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, For Country, 2020 - 2031
- Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019- 2031, (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, For Country, 2020 - 2031
- Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019- 2031, (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, For Country, 2020 - 2031
- Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019- 2031, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, For Country, 2020 - 2031
- Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019- 2031, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, For Country, 2020 - 2031
- Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019- 2031, (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, For Country, 2020 - 2031
- Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Country/Region, 2019- 2031, (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
- BASF SE
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Koninklijke DSM NV
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Shanghai Acebright Pharmaceuticals Group Co. Ltd.
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Xinfa Pharmaceutical Co. Ltd
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Hubei Guangji Pharmaceutical Co. Ltd
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- NB Group Co. Ltd
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Hegno
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Legend Industries
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Hebei Shengxue dacheng Pharmaceutical Co. Ltd
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Duchefa Biochemie
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Harman Finichem Ltd
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates

10. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. Section

References
Research Methodology
About Us and Sales Contact